Amsurg Corp. (AMSG) Earns “Positive” Rating from KeyCorp
AMSG has been the subject of several other reports. Jefferies Group reiterated a buy rating on shares of Amsurg Corp. in a research report on Sunday, July 3rd. Robert W. Baird reiterated a buy rating on shares of Amsurg Corp. in a research report on Thursday, June 16th. Zacks Investment Research raised Amsurg Corp. from a hold rating to a buy rating and set a $88.00 price target for the company in a research note on Monday, July 11th. Citigroup Inc. began coverage on Amsurg Corp. in a research note on Monday, September 26th. They issued a buy rating and a $79.00 price target for the company. Finally, Goldman Sachs Group Inc. reissued a buy rating on shares of Amsurg Corp. in a research note on Friday, June 17th. Three investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. The company presently has an average rating of Buy and an average price target of $92.09.
Shares of Amsurg Corp. (NASDAQ:AMSG) opened at 66.51 on Tuesday. Amsurg Corp. has a 12 month low of $58.37 and a 12 month high of $87.29. The company has a 50-day moving average price of $65.62 and a 200-day moving average price of $73.35. The firm has a market capitalization of $3.57 billion, a price-to-earnings ratio of 19.74 and a beta of 0.68.
Amsurg Corp. (NASDAQ:AMSG) last posted its earnings results on Tuesday, August 2nd. The company reported $1.10 EPS for the quarter, beating the consensus estimate of $1.08 by $0.02. The firm earned $758.50 million during the quarter, compared to the consensus estimate of $769.88 million. Amsurg Corp. had a return on equity of 8.20% and a net margin of 6.53%. The business’s quarterly revenue was up 21.5% on a year-over-year basis. During the same period last year, the company earned $0.97 earnings per share. Equities analysts forecast that Amsurg Corp. will post $4.33 EPS for the current fiscal year.
In related news, insider Robert Jon Coward sold 7,500 shares of the firm’s stock in a transaction that occurred on Friday, August 26th. The stock was sold at an average price of $63.65, for a total transaction of $477,375.00. Following the completion of the sale, the insider now owns 97,507 shares of the company’s stock, valued at $6,206,320.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 2.30% of the company’s stock.
Large investors have recently added to or reduced their stakes in the company. Emerald Acquisition Ltd. purchased a new position in shares of Amsurg Corp. during the second quarter valued at about $106,000. Smith Asset Management Group LP raised its position in shares of Amsurg Corp. by 8,500.0% in the second quarter. Smith Asset Management Group LP now owns 1,720 shares of the company’s stock valued at $133,000 after buying an additional 1,700 shares during the last quarter. Invictus RG raised its position in shares of Amsurg Corp. by 824.3% in the first quarter. Invictus RG now owns 1,904 shares of the company’s stock valued at $142,000 after buying an additional 1,698 shares during the last quarter. Checchi Capital Advisers LLC purchased a new position in shares of Amsurg Corp. during the second quarter valued at about $157,000. Finally, Advisor Group Inc. purchased a new position in shares of Amsurg Corp. during the second quarter valued at about $202,000. 98.42% of the stock is owned by institutional investors and hedge funds.
About Amsurg Corp.
AmSurg Corp. is a surgical center and physician services company. The Company is an owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology, children’s services, emergency medicine and radiology.
Receive News & Ratings for Amsurg Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amsurg Corp. and related companies with MarketBeat.com's FREE daily email newsletter.